The global Spatial Genomics & Transcriptomics market is expected to grow to USD 995.7 Million by 2029, up from USD 554.5 Million in 2024, at ...
Johnson & Johnson will spend more than $14 billion to delve further into the treatment of central nervous system disorders by purchasing Intra-Cellular Therapies. The health care giant said ...
J&J will buy all of Intra-Cellular's shares for $132 apiece, representing a 39% premium to their Friday closing price. Shares ...
NDA submitted to U.S. FDA for CAPLYTA® as adjunctive treatment for major depressive disorder; if approved, CAPLYTA® has potential to become a standard of care for most common depressive disorders ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
StockNews.com upgraded shares of United States Cellular (NYSE:USM – Free Report) from a sell rating to a hold rating in a research note published on Saturday. Other analysts have also recently issued ...
The drug, known as NXP800, works by targeting the heat shock factor 1 (HSF1) pathway, a cellular protective mechanism that is ...
The company has roaming agreements with 400+ cellular carriers worldwide, which are accessible from over 200 cruise ships. In those cases, travelers’ devices will automatically connect to the network ...